Hypokinetic azotemic osteodystrophy
Authors:
- Jorge B. Cannata-AndíaJCJorge B. Cannata-Andía
- Jorge J. CohenJCJorge J. Cohen
- John T. HarringtonJHJohn T. Harrington
- Nicolaos E. MadiasNMNicolaos E. Madias
- Cheryl J. ZusmanCZCheryl J. Zusman
- 1 September 1998
- journal article
- case report
- Published by Elsevier in Kidney International
- Vol. 54 (3) , 1000-1016
Abstract
No abstract availableKeywords
This publication has 85 references indexed in Scilit:
- SYSTEMIC ALUMINUM TOXICITY: EFFECTS ON BONE, HEMATOPOIETIC TISSUE, AND KIDNEYJournal of Toxicology and Environmental Health, 1996
- Staining of bone aluminium: comparison between aluminon and solocbrome azurine and their correlation with bone aluminium contentNephrology Dialysis Transplantation, 1996
- Aluminium toxicity: its relationship with bone and iron metabolismNephrology Dialysis Transplantation, 1996
- Adynamic bone lesion in renal transplant recipients with normal renal functionNephrology Dialysis Transplantation, 1996
- Trends in renal osteodystrophy: a survey from 1983 to 1995 in a total of 2248 patientsNephrology Dialysis Transplantation, 1996
- Bone disease in predialysis, hemodialysis, and CAPD patients: Evidence of a better bone response to PTHKidney International, 1995
- Mechanisms of aluminum-induced microcytosis: Lessons from accidental aluminum intoxicationKidney International, 1995
- Role of iron metabolism in absorption and cellular uptake of aluminumKidney International, 1991
- Demonstration of aluminium in iliac bone: correlation between aluminon and solochrome azurine staining techniques with data on flameless absorption spectrophotometry.Journal of Clinical Pathology, 1988
- Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients.Journal of Clinical Investigation, 1984